Page 7 - 2021_06-Haematologica-web
P. 7
haematologica Journal of the Ferrata Storti Foundation
2121 A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome
Mahesh Swaminathan et al.
https://doi.org/10.3324/haematol.2020.263392
Bone Marrow Transplantation
2131 Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect Eileen Haring et al.
https://doi.org/10.3324/haematol.2019.242990
Cell Therapy & Immunotherapy
2147 Endothelial damage and dysfunction in acute graft-versus-host disease Steffen Cordes et al.
https://doi.org/10.3324/haematol.2020.253716
Hemostasis
2161 An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study
Hanny Al-Samkari et al.
https://doi.org/10.3324/haematol.2020.261859
2170 Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia Karina Althaus et al.
https://doi.org/10.3324/haematol.2021.279000
Hematopoiesis
2180 Membrane protein CAR promotes hematopoietic regeneration upon stress Guojin Wu and Cheng Cheng Zhang
https://doi.org/10.3324/haematol.2019.243998
2191 MYB bi-allelic targeting abrogates primitive clonogenic progenitors while the emergence of primitive blood cells is not affected Zahir Shah et al.
https://doi.org/10.3324/haematol.2020.249193
2203 BMP signaling is required for postnatal murine hematopoietic stem cell self-renewal Sarah Warsi et al.
https://doi.org/10.3324/haematol.2019.236125
Myelodysplastic Syndromes
2215 Co-occurrence of cohesin complex and Ras signaling mutations during progression from myelodysplastic syndromes to secondary acute myeloid leukemia
Marta MartÃn-Izquierdo et al.
https://doi.org/10.3324/haematol.2020.248807
Non-Hodgkin Lymphoma
2224 Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B-cell-type diffuse large B-cell lymphoma
Lorenz Thurner et al.
https://doi.org/10.3324/haematol.2019.241653
2233 Genetic variation near CXCL12 is associated with susceptibility to HIV-related non-Hodgkin lymphoma Christian W. Thorbal et al.
https://doi.org/10.3324/haematol.2020.247023
Letters to the Editor
2242 The EBF1-PDGFRB T681I mutation is highly resistant to imatinib and dasatinib in vitro and detectable in clinical samples prior to treatment Thai Hoa Tran et al.
https://doi.org/10.3324/haematol.2020.261354
Haematologica 2021; vol. 106 no. 8 - August 2021 http://www.haematologica.org/
